UnitedHealth(US:UNH) Prnewswire·2024-06-26 14:05Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against UnitedHealth Group Incorporated due to allegations of misleading statements and failure to disclose material adverse facts regarding its business operations and relationships between its insurance unit and health-services arm [3][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses exceeding $100,000 in UnitedHealth stock or options between March 14, 2022, and February 27, 2024, to discuss their legal rights [1]. - A federal securities class action has been filed against UnitedHealth, with a deadline of July 15, 2024, for investors to seek the role of lead plaintiff [1][5]. - The complaint alleges that UnitedHealth made materially false and misleading statements and failed to disclose that proper firewalls between its Optum and UnitedHealthcare units were never established [3]. Group 2: Stock Performance and Market Reaction - Following the news of a DOJ investigation into UnitedHealth's operations, the company's stock price fell by $27.04, or 5.1%, closing at $498.28 per share on February 28, 2024 [4]. - The investigation focuses on the relationships between UnitedHealthcare and Optum, which may have implications for the company's operational integrity and investor confidence [4]. Group 3: Investor Communication and Participation - Faruqi & Faruqi encourages anyone with information regarding UnitedHealth's conduct, including whistleblowers and former employees, to contact the firm [5]. - Investors can choose to serve as lead plaintiffs or remain absent class members without affecting their ability to share in any recovery [5].